These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined treatment for locally advanced pancreatic cancer. Das M Lancet Oncol; 2019 Jul; 20(7):e351. PubMed ID: 31178373 [No Abstract] [Full Text] [Related]
4. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma. Martin RC J Gastrointest Surg; 2013 Oct; 17(10):1850-6. PubMed ID: 23929188 [TBL] [Abstract][Full Text] [Related]
5. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study. Choi Y; Oh DY; Kim K; Chie EK; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Ha SW; Bang YJ Cancer Res Treat; 2016 Jul; 48(3):1045-55. PubMed ID: 26511805 [TBL] [Abstract][Full Text] [Related]
6. Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma. Pollom EL; Koong AC; Ko AH Hematol Oncol Clin North Am; 2015 Aug; 29(4):741-59. PubMed ID: 26226908 [TBL] [Abstract][Full Text] [Related]
7. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. André T; Balosso J; Louvet C; Hannoun L; Houry S; Huguier M; Colonna M; Lotz JP; De Gramont A; Bellaïche A; Parc R; Touboul E; Izrael V Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):903-11. PubMed ID: 10705012 [TBL] [Abstract][Full Text] [Related]
9. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer? Kelly KN; Macedo FI; Merchant NB Adv Surg; 2020 Sep; 54():49-68. PubMed ID: 32713439 [No Abstract] [Full Text] [Related]
11. Management of locally advanced adenocarcinoma of the pancreas. Ryan DP; Willett CG Hematol Oncol Clin North Am; 2002 Feb; 16(1):95-103. PubMed ID: 12063831 [TBL] [Abstract][Full Text] [Related]
14. Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months. Shinagare AB; Ramaiya NH; Bellizzi AM; Mayer RJ Pancreatology; 2012; 12(1):35-8. PubMed ID: 22487471 [TBL] [Abstract][Full Text] [Related]
15. Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: report of a case. Turner K; Levi Sandri GB; Boucher E; Hénno S; Le Prisé E; Meunier B; Boudjema K; Sulpice L Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e29-31. PubMed ID: 25288453 [No Abstract] [Full Text] [Related]
16. [Combined locoregional therapeutic strategy in locally advanced cancers of the pancreas]. Manivit P; Polo R Ann Chir; 1998; 52(1):100. PubMed ID: 9752423 [No Abstract] [Full Text] [Related]
17. Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Bickenbach KA; Gonen M; Tang LH; O'Reilly E; Goodman K; Brennan MF; D'Angelica MI; Dematteo RP; Fong Y; Jarnagin WR; Allen PJ Ann Surg Oncol; 2012 May; 19(5):1663-9. PubMed ID: 22130621 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis. Strobel O; Büchler MW Nat Rev Gastroenterol Hepatol; 2013 Apr; 10(4):203-5. PubMed ID: 23478386 [No Abstract] [Full Text] [Related]
19. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Tempero MA; Arnoletti JP; Behrman SW; Ben-Josef E; Benson AB; Casper ES; Cohen SJ; Czito B; Ellenhorn JD; Hawkins WG; Herman J; Hoffman JP; Ko A; Komanduri S; Koong A; Ma WW; Malafa MP; Merchant NB; Mulvihill SJ; Muscarella P; Nakakura EK; Obando J; Pitman MB; Sasson AR; Tally A; Thayer SP; Whiting S; Wolff RA; Wolpin BM; Freedman-Cass DA; Shead DA; J Natl Compr Canc Netw; 2012 Jun; 10(6):703-13. PubMed ID: 22679115 [TBL] [Abstract][Full Text] [Related]